Citadel Advisors’s DA32 Life Science Tech Acquisition Corp. Class A Common Stock DALS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-584,130
| Closed | -$5.99M | – | 6834 |
|
|
2023
Q2 | $5.99M | Sell |
584,130
-143,192
| -20% | -$1.47M | ﹤0.01% | 1574 |
|
|
2023
Q1 | $7.36M | Buy |
727,322
+5,862
| +0.8% | +$59.3K | ﹤0.01% | 1516 |
|
|
2022
Q4 | $7.21M | Buy |
721,460
+425
| +0.1% | +$4.25K | ﹤0.01% | 1512 |
|
|
2022
Q3 | $6.99M | Buy |
721,035
+94
| +0% | +$911 | ﹤0.01% | 1568 |
|
|
2022
Q2 | $6.99M | Buy |
720,941
+125,000
| +21% | +$1.21M | ﹤0.01% | 1561 |
|
|
2022
Q1 | $5.81M | Buy |
595,941
+2
| +0% | +$19 | ﹤0.01% | 1938 |
|
|
2021
Q4 | $5.85M | Sell |
595,939
-15,978
| -3% | -$157K | ﹤0.01% | 1972 |
|
|
2021
Q3 | $6.02M | Buy |
+611,917
| New | +$6.02M | ﹤0.01% | 1890 |
|